IDEXX Laboratories (IDXX) Competitors $656.16 +0.65 (+0.10%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$656.02 -0.13 (-0.02%) As of 09/19/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDXX vs. NVST, ZTS, ISRG, BSX, SYK, MDT, BDX, EW, RMD, and DXCMShould you be buying IDEXX Laboratories stock or one of its competitors? The main competitors of IDEXX Laboratories include Envista (NVST), Zoetis (ZTS), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), and DexCom (DXCM). These companies are all part of the "medical" sector. IDEXX Laboratories vs. Its Competitors Envista Zoetis Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences ResMed DexCom IDEXX Laboratories (NASDAQ:IDXX) and Envista (NYSE:NVST) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Is IDXX or NVST more profitable? IDEXX Laboratories has a net margin of 24.41% compared to Envista's net margin of 2.11%. IDEXX Laboratories' return on equity of 64.42% beat Envista's return on equity.Company Net Margins Return on Equity Return on Assets IDEXX Laboratories24.41% 64.42% 29.89% Envista 2.11%4.84%2.68% Do insiders & institutionals believe in IDXX or NVST? 87.8% of IDEXX Laboratories shares are owned by institutional investors. 1.0% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 0.7% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, IDXX or NVST? IDEXX Laboratories has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500. Comparatively, Envista has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Do analysts prefer IDXX or NVST? IDEXX Laboratories presently has a consensus target price of $649.44, indicating a potential downside of 1.02%. Envista has a consensus target price of $20.92, indicating a potential upside of 0.06%. Given Envista's higher possible upside, analysts plainly believe Envista is more favorable than IDEXX Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IDEXX Laboratories 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.80Envista 1 Sell rating(s) 10 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.31 Which has preferable earnings & valuation, IDXX or NVST? IDEXX Laboratories has higher revenue and earnings than Envista. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIDEXX Laboratories$3.90B13.47$887.87M$12.0154.63Envista$2.51B1.38-$1.12B$0.3265.34 Does the media favor IDXX or NVST? In the previous week, IDEXX Laboratories had 23 more articles in the media than Envista. MarketBeat recorded 28 mentions for IDEXX Laboratories and 5 mentions for Envista. IDEXX Laboratories' average media sentiment score of 1.57 beat Envista's score of 0.27 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 26 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Envista 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryIDEXX Laboratories beats Envista on 14 of the 16 factors compared between the two stocks. Get IDEXX Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDXX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDXX vs. The Competition Export to ExcelMetricIDEXX LaboratoriesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$52.44B$6.82B$5.79B$10.40BDividend YieldN/A1.20%5.63%4.60%P/E Ratio54.6326.7876.4826.75Price / Sales13.47197.91531.72124.23Price / Cash52.7422.0337.9261.55Price / Book33.684.9813.726.40Net Income$887.87M$178.07M$3.29B$271.62M7 Day Performance2.34%5.36%2.66%3.46%1 Month Performance2.55%10.93%6.02%9.87%1 Year Performance29.49%17.52%80.02%28.45% IDEXX Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDXXIDEXX Laboratories4.1314 of 5 stars$656.16+0.1%$649.44-1.0%+26.9%$52.44B$3.90B54.6311,000Positive NewsAnalyst UpgradeHigh Trading VolumeNVSTEnvista3.6517 of 5 stars$21.14-0.8%$20.92-1.0%+8.1%$3.51B$2.51B66.0512,300Positive NewsZTSZoetis4.8289 of 5 stars$151.88-0.9%$202.43+33.3%-24.5%$67.31B$9.26B26.1413,800Positive NewsISRGIntuitive Surgical4.9504 of 5 stars$469.96+0.7%$595.95+26.8%-10.5%$168.47B$8.35B65.5515,638Positive NewsAnalyst RevisionBSXBoston Scientific4.8388 of 5 stars$108.14+0.9%$117.79+8.9%+16.9%$160.23B$16.75B64.3753,000Positive NewsAnalyst ForecastOptions VolumeSYKStryker4.9635 of 5 stars$393.12+0.2%$430.10+9.4%+3.2%$150.29B$22.60B52.0753,000News CoveragePositive NewsAnalyst ForecastMDTMedtronic4.9154 of 5 stars$92.91+0.0%$102.14+9.9%+6.1%$119.17B$33.54B25.5995,000Positive NewsBDXBecton, Dickinson and Company4.9599 of 5 stars$191.50-0.5%$211.44+10.4%-20.2%$54.89B$20.18B34.4474,000Positive NewsEWEdwards Lifesciences4.8067 of 5 stars$80.28-0.8%$85.90+7.0%+10.6%$47.13B$5.44B11.5515,800Positive NewsShort Interest ↑RMDResMed4.7463 of 5 stars$279.38+0.8%$278.36-0.4%+12.6%$40.90B$5.15B29.3810,600Positive NewsAnalyst ForecastDXCMDexCom4.9781 of 5 stars$77.99-3.1%$99.89+28.1%-6.2%$30.58B$4.03B54.1610,300Trending NewsOptions Volume Related Companies and Tools Related Companies NVST Alternatives ZTS Alternatives ISRG Alternatives BSX Alternatives SYK Alternatives MDT Alternatives BDX Alternatives EW Alternatives RMD Alternatives DXCM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDXX) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEXX Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEXX Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDXX Stock Alerts